Chronic Hives Clinical Study

Diagnosed with Chronic Hives

The cycle of chronic hives, also called chronic urticaria, can seem like it occupies every part of life. When the itching keeps coming back, it can feel like a never-ending struggle, even with treatment. That is why we are conducting a trial for those diagnosed with chronic spontaneous urticaria (CSU).

This clinical trial will evaluate the efficacy of remibrutinib in comparison to dupilumab in treating adult participants who have chronic spontaneous urticaria (CSU) that is not adequately controlled with antihistamines. The study drug is an oral medication taken twice a day and is being compared to an injection given every two weeks. Here is a bit more information about the trial:

  • Participants must be at least 18 years of age
  • This is a phase 3b clinical trial
  • You will need to visit the Study Doctor 8 times
  • The trial will last 28 weeks
Consider a Clinical Trial for CSU

Chronic hives may make many aspects of life feel out of control, especially when symptoms keep coming back.

Contact us to learn more about a clinical trial or fill out our research form.